Publications found:
36,694
Sort by:
Chronic Otitis Media (COM) - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Otitis Media (COM) - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+...
February 2021
60 pages
Chronic Pulmonary Infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Pulmonary Infections - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Chronic Traumatic Encephalopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Traumatic Encephalopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies...
February 2021
60 pages
Diabetic Cardiomyopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Diabetic Cardiomyopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pi...
February 2021
60 pages
Diabetic Ketoacidosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Diabetic Ketoacidosis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipe...
February 2021
60 pages
Egg allergy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Egg allergy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...
February 2021
60 pages
Endocarditis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Endocarditis – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drug...
February 2021
60 pages
ER+/ HER2 -ve Breast Cancer - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “ER+/ HER2 -ve Breast Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5...
February 2021
60 pages
Excessive Daytime Sleepiness - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Excessive Daytime Sleepiness - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Familial Mediterranean Fever - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Familial Mediterranean Fever - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
February 2021
60 pages
Gout - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Gout - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gou...
February 2021
60 pages
Hedgehog Pathway Inhibitors - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Hedgehog Pathway Inhibitors - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Hodgkin’s Lymphoma – Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Hodgkin’s Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipel...
February 2021
60 pages
Inflammatory Pain - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Inflammatory Pain - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
February 2021
60 pages
Inter Alpha Inhibitor Proteins - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Inter Alpha Inhibitor Proteins – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies an...
February 2021
60 pages
Lou Gehrig's Disease - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Lou Gehrig's disease – Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pip...
February 2021
60 pages
Lymphatic Malformations - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Lymphatic Malformations– Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pip...
February 2021
60 pages
MELAS Sundrome- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “MELAS Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline dr...
February 2021
60 pages
Metastatic Bone Pain- Pipeline insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Metastatic Bone pain – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pip...
February 2021
60 pages
Minimal Change Disease- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Minimal Change Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pip...
February 2021
60 pages
Molluscum Contagiosum - Pipeline Insight
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Molluscum Contagiosum - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pi...
February 2021
60 pages
Mucinous cystic neoplasm - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mucinous cystic neoplasm - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...
February 2021
60 pages
Nasal Polyposis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Nasal Polyposis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline d...
February 2021
60 pages
Natural Killer T Cell Lymphoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Natural Killer T Cell Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies an...
February 2021
60 pages
Necrobiosis Lipoidica - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Necrobiosis Lipoidica - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipe...
February 2021
60 pages
Necrotizing Enterocolitis – Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Necrotizing Enterocolitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+...
February 2021
60 pages
Netherton Syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Netherton Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipelin...
February 2021
60 pages
Niemann Pick C Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Niemann Pick C Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ p...
February 2021
60 pages
Opioid Withdrawal Syndrome-Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Opioid withdrawal syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+...
February 2021
60 pages
Palmoplantar Keratoderma- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Palmoplantar Keratoderma – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ p...
February 2021
60 pages
Palmoplantar Pustulosis- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Palmoplantar Pustulosis – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pi...
February 2021
60 pages
Pericarditis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pericarditis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drug...
February 2021
60 pages
Pneumococcal Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pneumococcal Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipel...
February 2021
60 pages
Polypoidal choroidal vasculopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Polypoidal choroidal vasculopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies...
February 2021
60 pages
Pre-Eclampsia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pre-Eclampsia – Pipeline Insight, 2021,” report provides comprehensive insights about companies and pipeline drugs in...
February 2021
60 pages
Pseudomonas aeruginosa infection - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pseudomonas aeruginosa infection - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies...
February 2021
60 pages
Rabies virus - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Rabies virus - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline dr...
February 2021
60 pages
Radiodermatitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Radiodermatitis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...
February 2021
60 pages
Refractory Metastatic Melanoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Refractory Metastatic Melanoma - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies a...
February 2021
60 pages
Refractory Multiple Myeloma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Refractory Multiple Myeloma – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5...
February 2021
60 pages
Refractory Status Epilepticus - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Refractory Status Epilepticus - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
February 2021
60 pages
Sebohrrea- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Seborrhea – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs i...
February 2021
60 pages
